![Wall Street closes higher as investors eye economic data, Fed comments](https://i-invdn-com.investing.com/news/external-images-thumbnails/LYNXMPEK5G0BG_L.jpg)
Please try another search
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Bret Barnes | 41 | 2021 | Independent Chairman of the Board & Member of Scientific Advisory Board |
Mark Brian White | 63 | 2023 | Interim CEO & Director |
Peter Laird | - | - | Member of Scientific Advisory Board |
Hui Shen | - | - | Member of Scientific Advisory Board |
Francis Colt deWolf | 56 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review